×
About 1,230 results

ALLMedicine™ Hereditary Hemorrhagic Telangiectasia Center

Research & Reviews  461 results

Prevalence of Intracranial Aneurysms in Hereditary Hemorrhagic Telangiectasia: Report f...
https://doi.org/10.3174/ajnr.A7505
AJNR. American Journal of Neuroradiology; Perez Akly MS, Vazquez C et. al.

May 20th, 2022 - Neurologic manifestations in hereditary hemorrhagic telangiectasia include an increased incidence of brain abscesses and ischemic strokes due to paradoxic embolization in addition to a wide spectrum of symptoms and complications due to typical bra...

Injection of cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
https://doi.org/10.1002/alr.23017
International Forum of Allergy & Rhinology; Anciaux M, Lebreton JP et. al.

May 7th, 2022 - Injection of cyanoacrylate glue for hereditary hemorrhagic telangiectasia.|2022|Anciaux M,Lebreton JP,Tonnerre D,Leclerc J,Dufour X,|

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Combined transarterial and transvenous embolization of multi-hole pial arteriovenous fi...
https://doi.org/10.1177/19714009221096829
The Neuroradiology Journal; Yamada H, Akiyama T et. al.

Apr 29th, 2022 - Pial arteriovenous fistula (AVF) is a vascular fistulous disease in which the cerebral pial artery and vein are directly connected without the intervening nidus within a sub-pial space. Multi-hole pial AVFs, wherein multiple feeders flow into one ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.14309/ajg.0000000000001755
The American Journal of Gastroenterology; Boland CR, Idos GE et. al.

Apr 27th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

see more →

Guidelines  3 results

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrha...
https://doi.org/10.7326/M20-1443
Annals of Internal Medicine; Faughnan ME, Mager JJ et. al.

Sep 8th, 2020 - Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular malformations (VMs). These result in chronic bleeding, acute hemorrhage, and c...

Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: p...
https://doi.org/10.1016/j.clinre.2020.03.008
Clinics and Research in Hepatology and Gastroenterology; Silvain C, Thévenot T et. al.

Apr 7th, 2020 - Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.|2020|Silv...

see more →

Clinicaltrials.gov  13 results

Sirolimus for Nosebleeds in HHT
https://clinicaltrials.gov/ct2/show/NCT05269849

Mar 8th, 2022 - The most common symptom of the hereditary hemorrhagic telangiectasia (HHT) disease is epistaxis. HHT is characterized by vascular (blood vessel) malformations, of the skin and mucus membranes of the nose (telangiectasia), gastrointestinal track, b...

Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry
https://clinicaltrials.gov/ct2/show/NCT04150822

Nov 22nd, 2021 - Background and Rationale HHT has an estimated prevalence of 1 in 5000, affecting children and adults, in multiple organs. The disease is characterized by the presence of vascular malformations (VMs), including arteriovenous malformations (AVMs) of...

The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
https://clinicaltrials.gov/ct2/show/NCT01507480

Oct 19th, 2021 - Antiangiogenic drugs, such as bevacizumab, are a new treatment strategy in Hereditary Hemorrhagic Telangiectasia (HHT). Its systemic administration in patients with HHT improves liver damage-related symptoms and epistaxis (cases reported and on-go...

Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
https://clinicaltrials.gov/ct2/show/NCT04139018

Aug 24th, 2021 - This study is a double-blinded, placebo-controlled, 8-week randomized clinical trial investigating the efficacy of timolol gel in the management of epistaxis in adults with HHT. The Specific Aims are to determine in adults with HHT-associated epis...

Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
https://clinicaltrials.gov/ct2/show/NCT02287558

Jul 15th, 2020 - This is a single-arm, open-label study that will investigate the efficacy and safety profile of pomalidomide in patients with genetically-documented Hereditary Hemorrhagic Telangiectasia (defined by characteristic mutations in Eng, Alk-1 or Smad-4...

see more →

News  14 results

Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines (2020)
https://reference.medscape.com/viewarticle/938166

Sep 30th, 2020 - The Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines were published on September 8, 2020.[1] Management of Epistaxis To reduce HHT-related epistaxis, use moisturizing topical therapies that humidify the nasal mucosa. Con...

Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines (2020)
https://reference.staging.medscape.com/viewarticle/938166

Sep 30th, 2020 - The Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines were published on September 8, 2020.[1] Management of Epistaxis To reduce HHT-related epistaxis, use moisturizing topical therapies that humidify the nasal mucosa. Con...

New Guidelines Expand Management Options for Hereditary Hemorrhagic Telangiectasia
https://www.staging.medscape.com/viewarticle/937096

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

New Guidelines Expand Management Options for Hereditary Hemorrhagic Telangiectasia
https://www.medscape.com/viewarticle/937096

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

Drug Shows 'Striking' Efficacy in Hereditary Bleeding Disorder
https://www.medscape.com/viewarticle/932558

Jun 18th, 2020 - Bevacizumab has shown efficacy in the treatment of hereditary hemorrhagic telangiectasia (HHT), a rare, progressive bleeding disorder for which there are currently no approved therapies. The finding comes from the InHIBIT-Bleed trial, results from...

see more →

Patient Education  1 results see all →